Tate & Lyles survey of 500 current and former GLP-1 users across North America paints a picture of consumers who arent just eating less, but eating differently and expecting foods to work harder for them
By activating GLP-1 receptors, these medications reduce hunger signals, increase feelings of fullness, and help regulate blood sugar
But even in the most conservative scenario, with perfect overlap, roughly 20 million Americans (30% of 70 million) will become eligible for GLP-1 insurance coverage this year
In addition, you must meet one of the three clinical criteria set by CMS, measured at the time you start GLP-1 therapy: BMI of 35 or higher (and age 18 or older), or BMI of 30 or higher (and age 18 or older), plus one of the following: heart failure with preserved ejection fraction, uncontrolled high blood pressure (systolic above 140 or diastolic above 90 despite treatment with two blood pressure medications), or chronic kidney disease stage 3a or above, or BMI of 27 or higher (and age 18 or older), plus one of the following: prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease If you take a GLP-1 for another condition, the Bridge is not for you